Jeff Aronin is an entrepreneur and CEO of Paragon Biosciences. In 1989 he received his first degree in marketing. Jeff proceeded to further his education and was later awarded a Bachelor of Science degree from Northern Illinois University and an M.B.A. from DePaul University.
Jeff’s journey to become an entrepreneur in the biopharmaceutical sector started when he tailed a physician who was treating a patient with epilepsy. The patient was experiencing seizures, and the doctor’s option was to remove a part of his brain. Jeff watched as the physician pursued a different method for treating the seizures in order to avoid brain surgery. This is when Aronin found his passion for pharmaceutical development which later led him to start his own business.
Since then, Jeff Aronin has worked in the biopharmaceutical field for over 20 years. Jeff has worked for several companies, and this has helped grow his skills tremendously. However, apart from businesses, he is also a philanthropist who seeks to boost the surrounding community. Aronin was appointed by the Chicago Mayor Rahm Emanuel as a member on the board of directors and this led to a partnership between public and private stakeholders (http://chicago.blueskyinnovation.com/vault/network/aronin-jeff/). This was an excellent position for Jeff to contribute positively to the community and help in stirring economic development in the region.
Paragon Biosciences was founded in 2010, and the company’s main objective is to improve people’s lives through biomedical innovations and to provide new drugs for diseases that have few or no options available. The company does so by building up biotechnology startups.
Some of the companies developed under Paragon bioscience’s guidance include:
Castle Creek Pharmaceuticals
This company is tasked with innovating treatments for patients with severe dermatological conditions. The company has a wide range of products that have the potential to treat these conditions and help better people’s lives.
This is the second company under Paragon Biosciences and it is responsible for research and innovation of drugs that help patients with central nervous illnesses and sleep disorders.
Decade is a research program that focuses on unusual Alzheimer’s disease treatment and developing therapies that will help improve patient’s life.
This organization conducts research and is in charge of developing treatments for conditions involved with tumors.